About Thyrocare International Limited
Data last updated:
Thyrocare International Limited was a public limited company based in Navi Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the financial holding companies segment of the financial services sector. It was incorporated on 14 May 2012.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PLC230995.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹15 Lakh. It was led by directors including Anand Velumani and Velumani Arokiaswamy.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 2nd Floor Plot No: D – 123 Ttc MIDC Village Shirvane Node Nerul, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2020, the company reported a revenue of ₹13.39 Lakh. For the same year it recorded a net profit of ₹10.05 Lakh (net margin 75%) and EBITDA of -₹68,828 (EBITDA margin -5.1%).
The last known website on record is thyrocare.com.
Company details
Contact details
Thyrocare International Limited's registered office is in Navi Mumbai, Maharashtra. Its website is thyrocare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Apps
- Registered Address2nd Floor Plot No: D – 123 Ttc MIDC Village Shirvane Node Nerul, Navi Mumbai, Maharashtra, India – 400706
- IndustryFinancial Services, Financial Holding Companies
To see the full contact details of Thyrocare International Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Thyrocare International Limited
FY 2022 filings availableThyrocare International Limited reported revenue of ₹13.39 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹13.39 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹68,828 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.1% | ||||
| Net Profit Margin | 75% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Thyrocare International Limited, buy the company report.
Board of directors of Thyrocare International Limited
Thyrocare International has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Velumani | Director | 14 May 2012 | 14 Years 5 Months | As last reported |
| Velumani Arokiaswamy Also directs: Focus Value LLP, Mahima Advertising LLP, Emerald Jewel Industry India Limited and 3 more | Director | 14 May 2012 | 14 Years 5 Months | As last reported |
| Sundararaju Arokiaswamy | Director | 14 May 2012 | 14 Years 5 Months | As last reported |
Shareholding
The shareholding of Thyrocare International Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Thyrocare International Limited, buy the company report.
Legal cases
No court or tribunal cases involving Thyrocare International Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Thyrocare International Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Thyrocare International Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Thyrocare International Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Rajendra Bhaskar Halve ceased to be Director on 12 May 2017.
News
Frequently asked questions
Thyrocare International has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Thyrocare International was a public limited company based in Navi Mumbai, Maharashtra, India. The company worked in financial holding companies, within the financial services industry. It was incorporated on 14 May 2012 and is registered under CIN U74120MH2012PLC230995. The company has been struck off by the Registrar of Companies and is no longer operational.
Thyrocare International had 3 directors:
- Anand Velumani - Director
- Velumani Arokiaswamy - Director
- Sundararaju Arokiaswamy - Director
The CIN (Corporate Identification Number) of Thyrocare International is U74120MH2012PLC230995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Thyrocare International is at 2nd Floor Plot No: D – 123 Ttc MIDC Village Shirvane Node Nerul, Navi Mumbai, Maharashtra, India – 400706.
Thyrocare International was incorporated on 14 May 2012. It is registered with the Registrar of Companies, Mumbai.
Thyrocare International can be reached through the website thyrocare.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The latest financial statements of Thyrocare International on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
Thyrocare International operated in the financial services industry, in the financial holding companies segment. It worked in this industry before it was struck off.
Rajendra Bhaskar Halve ceased to be Director on 12 May 2017. Anand Velumani was appointed as Director on 14 May 2012. Sundararaju Arokiaswamy was appointed as Director on 14 May 2012. Thyrocare International has 4 board changes on record in total.